🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Непрекъснатото назално вдишване може да причини ерозия на носната лигавица, потенциално водеща до кръвотечение от носа, инфекции, перфорация на преградата и нарушено назално дишане. Може също да наруши нормалното качество и физиологичния процес на вдишване на въздух. Продължителните ефекти включват риск от хипоксия, която може допълнително да доведе до различни усложнения в тялото и може да запуши дихателните пътища. Продуктът не отговаря на изискванията на Директивата за общата безопасност на продуктите.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Withdrawal of the product from the market
Date of entry into force
11/09/2024
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Risk Description (original English): Continuous nasal inhalation may cause nasal mucosa erosion, potentially causing nosebleeds, infections, septum perforation, and impaired nasal breathing. It may also disrupt the normal quality and physiological process of air inhalation. Prolonged effects include the risk of hypoxia, which can further result in various complications within the body and may obstruct the respiratory pathways.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.